Early Genetic Testing Could Shorten the Path to an Usher Syndrome Diagnosis

A 2026 study found that early genetic panel testing delivered a clinically actionable diagnosis in 44.6% of people with suspected genetic eye diseases. Usher syndrome was the most common diagnosis, led by USH2A-associated type 2 Usher syndrome, supporting earlier molecular testing as a way to guide evaluation, counseling, and future gene-specific care.